CannabisNewsBreaks

MondaySep 26, 2022 10:22 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Expands Global Footprint to Add 3 International Markets

Flora (NASDAQ: FLGC) is a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands. The company today announced that it has completed its first exports of Colombian grown high-CBD dried cannabis flower to Switzerland and the Czech Republic as well as CBD isolate to the United States. “As our global distribution network continues to evolve, adding these three industry-leading countries to our footprint is a major milestone for Flora,” said Luis Merchan, chairman and CEO of Flora Growth. “Our cultivation operation in Colombia, which provides high-quality, high-margin flower and derivatives, has experienced increasing demand. These exports are…

Continue Reading

FridaySep 23, 2022 2:41 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces 2022 Financial Results, Business Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today reported financial results for the fiscal year ended June 30, 2022. “In the final quarter of our fiscal 2022, as well as throughout the previous fiscal year, we have made important advancements in our pharmaceutical drug development programs, including expanding our phase 2 clinical trial for the treatment of symptoms related to epidermolysis bullosa to include adolescents, and initiating a research collaboration agreement to further screen cannabinoid analogs for potential therapeutic uses. As announced on Sept. 8, 2022, we have…

Continue Reading

ThursdaySep 22, 2022 2:58 pm

CannabisNewsBreaks – REZYFi Inc. Stands Distinct with Service to State-Licensed Cannabis Industry, Proprietary Technology

REZYFi, a cannabis mortgage bank servicing the needs of both traditional and non-traditional consumers and businesses, is one of the first mortgage bankers of its kind in the United States. The company is leveraging its position in a market where most traditional lenders remain diffident to serve the state-licensed cannabis industry. “Through its two wholly owned subsidiaries – REZYFi Lending and ResMac Inc. – REZYFi is targeting licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financing,”…

Continue Reading

ThursdaySep 22, 2022 12:13 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) CEO, Inventor of GrowPods Share Insight on the Future of Farming

Advanced Container Technologies (OTC: ACTX) was featured in a recent episode of “Gamechangers LIVE.” Doug Heldoorn, CEO of ACTX, the exclusive U.S. distributor of GrowPods — self-contained, hydroponic “micro-farms,” and Shannon Illingworth, the inventor of GrowPods, joined the podcast to discuss the future of farming in America and the world. According to a recent Wall Street Journal article, the global food supply is in critical condition. The Guardian further projects that the world’s population is expected to reach nearly 10 billion by 2050 and will require a 70% increase in global food production but speculates today’s food systems are not…

Continue Reading

TuesdaySep 20, 2022 2:30 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Hypertension Drug Market with Proprietary Drug-Delivery Method

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is focused on establishing a stronghold in the $28 billion hypertension drug market. The company’s exclusive therapeutic, DehydraTECH-CBD, has shown exciting potential as an alternative to traditional cannabidiol (“CBD”) dosing methods; the proprietary treatment may offer improved and more rapid absorption of drugs into the bloodstream and brain. According to the announcement, only one FDA-approved CBD drug is currently available on the market; that drug is for pediatric epilepsy. Lexaria is working to offer the second-ever, FDA-approved CBD therapeutic, designed to treat hypertension. The market for the treatment is tremendous,…

Continue Reading

TuesdaySep 20, 2022 1:13 pm

CannabisNewsBreaks — Lift&Co. Expo Announces Vancouver Cannabis Conference & Trade Show After Three-Year Break

Lift&Co. Expo has announced the dates for its upcoming event, the first one scheduled after a three-year paused caused by the COVID-19 pandemic. The event, which will be held in Vancouver, British Columbia, is slated for Jan. 12–14, 2023. Lift&Co. is Canada's number-one cannabis conference and trade show, and the organization has released information about its Lift&Co. Expo Vancouver agenda. The expo will include a business conference on Thursday, Jan. 12, followed by industry days on Friday and Saturday, Jan. 13–14. The event also has a consumer day on Jan. 14; the expo officially ends with an after party that…

Continue Reading

TuesdaySep 20, 2022 10:48 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Release FY 2022 Financial Report, Corporate Update

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, will be releasing its financial report for fiscal year 2022, the period ended June 30, 2022, later this month. The company has announced that it will release the financial report, along with business highlights, on Sept. 23, 2022. In addition, the company has announced a conference call and webcast to be held the same day at 1 p.m. ET. Those interested in listening in on the conference call can register for the call; they will then receive information about how to dial in to the…

Continue Reading

FridaySep 16, 2022 12:07 pm

CannabisNewsBreaks – CannabisNewsWire to Heighten Visibility of Lift&Co. Expo Vancouver 2023

IBN (“InvestorBrandNetwork”), an innovative content distributor and multifaceted communications organization with 50+ brands, including CannabisNewsWire, today announced that it will be collaborating with the organizers of Lift&Co. Expo. The industry-leading event will return to the Vancouver Convention Centre in Vancouver, BC, on Jan. 12-14, 2023. Lift&Co. Expo will feature 200+ exhibitors, industry professionals, seasoned investors, recreational and medicinal consumers and specialized media outlets. As a media partner, CannabisNewsWire will generate specialized content and further the distribution and publication through social media strategies and channel and digital partners to heighten the visibility of the conference, speakers and exhibitors. “We are always…

Continue Reading

FridaySep 16, 2022 11:04 am

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) Featured on ‘Gamechangers LIVE’

Advanced Container Technologies (OTC: ACTX) was featured in a recent episode of “Gamechangers LIVE.” The podcast series shines a spotlight on individuals who are gamechangers in their fields and shares perspective on their journeys, mindsets, struggles and successes in an effort to inspire and inform listeners. Doug Heldoorn, ACTX chairman and CEO, and Shannon Illingworth joined the broadcast, hosted by executive coach and speaker Sergio Tigera, to discuss the origins of Advanced Container Technologies and the ways it is working to revolutionize farming practices. “When I was speaking with Shannon – I’ve known him for 15 years – we were…

Continue Reading

ThursdaySep 15, 2022 1:39 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Hypertension Treatment Program Stands Distinct

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently provided information to its stakeholders to help them conveniently research and understand different non-affiliated third-party sources and their methodologies for valuing biotech and pharmaceutical companies. The information includes a discussion of underlying logic-based evaluations that offer a realistic framework of expectations that investors can use in their analysis. “One of the logic-based evaluations considers the stage at which a company’s drug development program has reached. According to the U.S. Food and Drug Administration (‘FDA’), there are five steps to the drug development process: discovery and development, preclinical research, clinical research, FDA drug review, and,…

Continue Reading